OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert ABBV.../  DE000ME6LEC1  /

Stuttgart
10/7/2024  11:14:06 AM Chg.-0.14 Bid11:32:04 AM Ask11:32:04 AM Underlying Strike price Expiration date Option type
117.34EUR -0.12% 117.39
Bid Size: 100		 118.00
Ask Size: 100		 AbbVie Inc - USD 12/31/2024 Call
GlobeNewswire 8/29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire 8/28 Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
GlobeNewswire 8/28 Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire 8/23 NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Confere...
GlobeNewswire 8/19 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire 8/15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 8/15 Soleno Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 8/14 ArriVent BioPharma Reports Second Quarter 2024 Financial Results
GlobeNewswire 8/9 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...
GlobeNewswire 8/8 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/8 Aligos Therapeutics Strengthens Board with Two New Independent Directors
GlobeNewswire 8/8 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 8/8 Genmab Updates 2024 Financial Guidance
GlobeNewswire 8/8 Royalty Pharma Reports Second Quarter 2024 Results
GlobeNewswire 8/7 Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/6 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/1 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 8/1 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 8/1 NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
GlobeNewswire 8/1 Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.
GlobeNewswire 7/31 Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
GlobeNewswire 7/31 Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...
GlobeNewswire 7/30 Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire 7/28 Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...
GlobeNewswire 7/25 Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...